MedPath

Study of preventive effect of selenium in cisplatin induced nephrotoxicity

Phase 2
Conditions
Acute renal failure due to Cisplatin.
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions
Registration Number
IRCT138901213678N1
Lead Sponsor
Research deputy of Ahvaz Jundishapur university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients who were referred to Shafa hospital for chemotherapy with Cisplatin1388-1389
Exclusion criteria:1) serum Creatinine more than 1.5mg/dl in man and more than 1.4mg/dl
in woman
2) Use of other nephrotoxic drug such as NSAID, ACEI, Aminoglycoside
at 2 weeks later
3) Sepsis
4) Pancytopenia
5) Patient who refused Selenium

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath